Consumer Health Cancer / Oncology

Biostar Pharma Enrolls First Patient for Phase 1 Study of UTD2, World's First Oral Epothilone Anti-Cancer Drug

This study will be conducted at multiple clinical research centers including Sarah Cannon Research Institute (Florida Cancer Specialists & Research Ins...

 June 13, 2023 | News

HKSH Medical Group and UCLA Health signed a Development Agreement

HKSH Medical Group (HKSH) and UCLA Health have signed a Development Agreement to strengthen their partnership in knowledge transfer in cancer management. T...

 June 13, 2023 | News

Dizal Highlights Oncology Pipeline Strength at 2023 ASCO, Leading China's Biotech Innovation

Two highly anticipated oral presentations captured attention: first pivotal study of sunvozertinib (WU-KONG6) and multinational pivotal study of golidoci...

 June 08, 2023 | News

Agilent BioTek Celebrates a Decade of Cell Imaging and Microscopy Innovation

Agilent Technologies Inc. (NYSE: A) announces the 10th anniversary of the Agilent BioTek Cytation 3 cell imaging multimode reader and the Agilen...

 June 01, 2023 | News

Lunit and the JNCCHE Partner in AI Pathology to Advance Precision Oncology

  Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center...

 May 31, 2023 | News

AMP945 and FOLFIRINOX Synergize for Enhanced Pancreatic Cancer Treatment

  Amplia's highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of pancreatic ...

 May 30, 2023 | News

Merck Highlights Commitment to Improving Cancer Outcomes

Merck, a leading science and technology company, today announced that 43 abstracts covering several modalities and mechanisms will be presented at the 2023...

 May 29, 2023 | News

Leading New Zealand Cancer Research Gets a Data Privacy Boost with Amaroq Therapeutics and GeneCrypt Partnership

Amaroq Therapeutics, a world-leading company based in New Zealand focused on developing a new class of therapeutics that targets long non-coding ...

 May 26, 2023 | News

Discovery Life Sciences Joins Akoya Biosciences' Global Network to Boost Immuno-Oncology Research

With this qualification, Discovery gains access to Akoya's PhenoImager® HT workflows, which can provide insights into the tumor microenvironment (...

 May 19, 2023 | News

Fujitsu partners with Takeda and National Cancer Center Japan to analyze and visualize ovarian cancer patient journey

Fujitsu today announced that it has conducted a joint research project with Takeda Pharmaceutical Company Limited and the National Cancer Center Japan to a...

 May 12, 2023 | News

Thermo Fisher & Pfizer team up to bring cancer testing to global markets

Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access t...

 May 10, 2023 | News

EirGenix's Breast Cancer Biosimilar EG1206A Meets Phase 1 Trial Goals

Comparing EG1206A to Roche's Perjeta® US and EU, results of the clinical data analysis show that the main test indicators have met the pharmacokinetics...

 May 08, 2023 | News

ABM Initiates Phase I Clinical Trial of MEK Inhibitor for Solid Tumor, Doses First Patient

MEK (mitogen-activated protein kinase kinase), a key kinase of the MAPK pathway, is frequently activated in various cancers, including those with RAS mutat...

 May 05, 2023 | News

The Impact of Digital Health Technologies in Oncology: Current State and Future Directions

Digital health has revolutionized the way healthcare is delivered and managed in recent years. Oncology is one field that has benefited significantly from ...

 May 03, 2023 | Opinion


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close